Equities
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)5,790.00
  • Today's Change-25.00 / -0.43%
  • Shares traded4.35m
  • 1 Year change+39.15%
  • Beta0.4867
Data delayed at least 15 minutes, as of Feb 20 2026 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2025202520242023
ASSETS
Cash And Short Term Investments405,589472,889553,704
Total Receivables, Net725,254697,610681,693
Total Inventory1,217,3491,209,869986,457
Prepaid expenses------
Other current assets, total173,000178,212176,102
Total current assets2,521,1922,558,5802,397,956
Property, plant & equipment, net1,968,2091,989,7771,691,229
Goodwill, net5,324,4305,410,0674,790,723
Intangibles, net3,631,5604,274,6824,269,657
Long term investments361,926430,608378,857
Note receivable - long term------
Other long term assets70,28251,21363,325
Total assets14,248,34415,108,79213,957,750
LIABILITIES
Accounts payable308,450319,955307,453
Accrued expenses------
Notes payable/short-term debt74,621251256
Current portion long-term debt/capital leases474,318367,000339,344
Other current liabilities, total1,649,1321,625,8971,834,887
Total current liabilities2,506,5212,313,1032,481,940
Total long term debt3,966,3264,476,5014,042,741
Total debt4,515,2654,843,7524,382,341
Deferred income tax35,470118,158295,178
Minority interest895741549
Other liabilities, total804,048927,025783,219
Total liabilities7,313,2607,835,5287,603,627
SHAREHOLDERS EQUITY
Common stock1,694,6851,676,5961,676,345
Additional paid-in capital1,775,7131,747,4141,728,830
Retained earnings (accumulated deficit)1,187,5861,391,2031,541,146
Treasury stock - common(74815)(51259)(100317)
Unrealized gain (loss)4,75715,72912,470
Other equity, total2,347,1582,493,5811,495,649
Total equity6,935,0847,273,2646,354,123
Total liabilities & shareholders' equity14,248,34415,108,79213,957,750
Total common shares outstanding1,5741,5691,555
Treasury shares - common primary issue171328
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.